Koyfin Home > Directory > Health Care > ANI Pharma Inc > Capital Expenditures

ANI Pharma Inc Capital Expenditures Chart (ANIP)

ANI Pharma Inc annual/quarterly Capital Expenditures from 2012 to 2020.
  • ANI Pharma Inc Capital Expenditures for the quarter ending June 06, 2020 was $-1m a -110.07% increase of 1m year over year
  • ANI Pharma Inc Capital Expenditures for the last 12 months ending June 06, 2020 was $-5m a -8.18% increase of 0m year over year
  • ANI Pharma Inc Annual Capital Expenditures for 2019 was $-7m a 13.44% decrease of -1m from 2018
  • ANI Pharma Inc Annual Capital Expenditures for 2018 was $-6m a -80.55% increase of 5m from 2017
  • ANI Pharma Inc Annual Capital Expenditures for 2017 was $-10m a 55.96% decrease of -6m from 2016
Other Cash Flow Metrics:
  • ANI Pharma Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $8m a -89.99% decrease of -7m year over year
  • ANI Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $5m a 695.36% increase of 35m year over year
  • ANI Pharma Inc Total Revenue for the quarter ending December 12, 2018 was $57m a 18.63% increase of 11m year over year
View Chart On Koyfin

Quarterly ANIP Capital Expenditures Data

06/2020$-1m
03/2020$-2m
12/2019$-2m
09/2019$-2m
06/2019$-2m
03/2019$-2m
12/2018$-1m
09/2018$-1m
06/2018$-1m
03/2018$-2m

Annual ANIP Capital Expenditures Data

2019$-7m
2018$-6m
2017$-10m
2016$-5m
2015$-2m
2014$-1m
2013$0m
2012$0m
2011$0m